BPOP vs SNEX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BPOP's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. Despite strong profitability metrics and robust earnings growth, the lack of Altman Z-Score and missing key financial data (Debt/Equity, cash/debt levels) limits confidence in structural safety. The stock trades below analyst target and intrinsic value estimates but faces headwinds from bearish insider activity and weakening technical momentum. Solid dividend coverage and sector-leading earnings surprises provide offsetting positives.
SNEX exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and explosive growth metrics. While the current price of $106.03 is significantly above the defensive Graham Number ($56.77), it remains below the growth-based Intrinsic Value of $131.57, suggesting room for appreciation. The company is delivering exceptional YoY earnings growth (47.9%) and a consistent track record of earnings beats. However, the valuation is balanced against extreme leverage (Debt/Equity of 8.06) and razor-thin profit margins typical of high-volume capital markets firms.
Compare Another Pair
Related Comparisons
BPOP vs SNEX: Head-to-Head Comparison
This page compares Popular, Inc. (BPOP) and StoneX Group Inc. (SNEX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.